Color Is Here™

Chief Executive Officer
erik@enchroma.com

To EnChroma, Erik brings 25 years of success in organizational strategy, brand management, performance marketing, merchandising, talent management, and eCommerce operations. Most notably, he served as Chief Commercial Officer for Zenni Optical, the largest online provider of prescription eyewear, where he led all merchandising, marketing, UX/UI, and IT functions. As a consultant, Erik has led branding, advertising and communications campaigns for major brands such as Microsoft, Google, Blue Shield, Red Bull, Ticketmaster, and other Fortune 500 clients.

Chief Science Officer, Co-Founder & Inventor
don@enchroma.com

Don McPherson, Doctor of Glass Science, is the inventor of EnChroma eyewear for color blindness. He invented laser safety glasses for surgeons, which were discovered to have a simultaneously positive effect on the vision of people with color blindness. Don subsequently received three SBIR grants from the US Small Business Administration, leading to the formation of EnChroma. In addition to EnChroma, Don served as President of Bay Glass Research, and Founder and Vice President of Research and Development at Vetrazzo. Don is the recipient of five NEI, NIH, and NCI grants and has authored eight patents and 14 scientific papers. In 2017, Don was awarded a PhD honoris causa and in 2018, was named a Lemelson AAAS Invention Ambassador by the American Association for the Advancement of Science.

Managing Director, EnChroma International
tony@enchroma.com

Tony Dykes, co-founder of EnChroma, previously served as the company's CEO from 2010-2016. Tony has deep experience working with inventors and startup companies. He helped raise the initial capital to launch EnChroma and worked closely with Don to bring its eyewear for colour blindness to market. Tony also currently serves as CEO for NovolBio, an early stage bioplastic eyeglass lens producer. Previously, he practiced corporate law in Silicon Valley, providing legal services to emerging technology clients. Tony earned his Juris Doctorate from the New York University School of Law and his undergraduate degree from the University of California, Berkeley.

Executive Chairman

Bob Dykes is currently the Executive Chairman of EnChroma, Executive Chairman of CloudVector, and a member of the Advisory Board of Bitfury. He has been an executive in Silicon Valley since 1983, holding CEO, President, CFO and COO positions at companies including Symantec, Flextronics, Juniper Networks, Verifone, NebuAd, Tangerine, Adept Technologies and CloudVector, and board positions with Trust Company of America. He holds a BCA from Victoria University of Wellington, New Zealand.

Board Member

Peter is a recognised leader of global media and consumer product companies. As former President and CEO of Marvel, Peter led a turnaround from 1999 to 2009 and grew the company into one of the world’s leading entertainment brands. Peter was also President and CEO of Remington Products Company, Security Hardware Group of the Black & Decker Corporation, President of Bristol-Myers Squibb Pharmaceutical Group in Canada and President of the Clairol Personal Care Division.At present, Peter is Chairman for Iconix Brand Group and is currently the Managing Principal of Cuneo & Company, LLC, a private investment and management company. Cuneo & Co. is focused on making investments in private companies within the consumer, media and entertainment oriented industries. Peter is currently or has been a board member of public and private companies such as Marvel Entertainment Inc., Iconix Brand Group, WaterPik Technologies Inc. and Remington Products. He also sits on the Board of the National Archives Foundation in Washington, DC. He served two tours as a Lieutenant in the U.S. Navy in the Vietnam War and was Damage Control Officer and then Communications Officer on the USS Joseph Strauss (DDG-16). Peter received his MBA from Harvard Business School and holds a B.S. in Glass Science from Alfred University, where he has served on the Board of Trustees since 1990.

Board Member

Nagesh Rao, a new EnChroma board member, has worked in the public, private, and NGO sectors for over 20 years. He is a highly regarded CivicTech leader, having co-led the creation of programmatic efforts such as i6 Green, Patents for Humanity, Growth Accelerator Fund Competition, and USAID’s-SBAR Program. Nagesh previously oversaw key digital products and services such as SBA.gov, SBIR.gov, Certify 2.0, Lender Match, and served on the US Small Business Administration's COVID-19 Leadership response team leading the technical direction of PPP and EIDL efforts as part of the historic CARES Act implementation. Nagesh has curated IP-Portfolios and growth strategies for a number of organisations and currently serves as a Technical and Venture Advisor to Ruvna and MAS Holdings. He is a 2004 Mirzayan Fellow of The National Academies and a 2016 USA Eisenhower Fellow. He earned a BSc from Rensselaer Polytechnic Institute, a MSc from Albany Law School-Union University, and his MBA from the University of Maryland-College Park.

Board Member

Catherine Ireland, MD, NMD, LAc, is a physician who specializes in pain management, naturopathic medicine and acupuncture. In addition, she was the owner of To Your Points and Optima Wellness, two providers of integrative medicine for pain management in New York City and Portland, OR. Dr. Ireland served as secretary, treasurer and medical director for international medical Non-Governmental Organizations (NGOs). She also helped launch, document adverse events from, and ensure Food and Drug Administration compliance of GlaxoSmithKline's weight loss medication alli. Dr. Ireland’s training and licensure spans anesthesiology (University of Connecticut Health Center), surgery (Brookdale University Hospital and Medical Center), acupuncture (Phoenix Institute of Herbal Medicine and Acupuncture), naturopathy (Southwest College of Naturopathic Medicine), molecular environmental biology with an emphasis in microbiology (University of California, Berkeley), yoga (Southwest Institute of Healing Arts), and mindfulness-based cognitive therapy (Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital).